MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Accuray Incorporated EV/EBITDA Ratio 2011-2026 | ARAY
Annual EV/EBITDA Ratio Accuray Incorporated
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 19.9 | 14.2 | 40 | 61.7 | 53.9 | 39.6 | 1.94 K | 300 | -10.4 | -12.8 | -15.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.94 K | -15.4 | 221 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
11 | $ 12.07 | 0.33 % | $ 1.63 B |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | USA |
 |
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | USA |
 |
Butterfly Network
BFLY
|
-3.9 | $ 4.15 | 0.97 % | $ 878 M | USA |
 |
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
-2.13 | $ 36.68 | -0.22 % | $ 5.46 K | USA |
 |
Cutera
CUTR
|
236 | - | -10.19 % | $ 1.99 M | USA |
 |
Boston Scientific Corporation
BSX
|
25.2 | $ 62.35 | -0.75 % | $ 92.3 B | USA |
 |
AxoGen
AXGN
|
-19.1 | $ 32.46 | -5.75 % | $ 1.49 B | USA |
 |
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | USA |
 |
Align Technology
ALGN
|
48.9 | $ 171.5 | 0.53 % | $ 12.8 B | USA |
 |
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | USA |
 |
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M |  Canada |
 |
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | USA |
 |
Alphatec Holdings
ATEC
|
-8.6 | $ 10.88 | 0.46 % | $ 1.63 B | USA |
 |
TELA Bio
TELA
|
-5.89 | $ 0.62 | 3.21 % | $ 29.1 M | USA |
 |
Invacare Corporation
IVC
|
1.89 | - | - | $ 24.7 M | USA |
 |
ClearPoint Neuro
CLPT
|
-9.73 | $ 9.37 | - | $ 265 M | USA |
 |
CONMED Corporation
CNMD
|
40.2 | $ 33.91 | -2.53 % | $ 1.05 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.61 | 3.77 % | $ 38 M | USA |
 |
Delcath Systems
DCTH
|
-1.69 | $ 9.71 | 0.83 % | $ 348 M | USA |
 |
EDAP TMS S.A.
EDAP
|
730 | $ 3.51 | 3.39 % | $ 131 M |  France |
 |
Edwards Lifesciences Corporation
EW
|
39.2 | $ 80.85 | -0.25 % | $ 47.3 B | USA |
 |
FONAR Corporation
FONR
|
-33.4 | $ 18.59 | -0.01 % | $ 122 M | USA |
 |
Electromed
ELMD
|
26.4 | $ 23.43 | 0.6 % | $ 198 M | USA |
 |
Helius Medical Technologies
HSDT
|
-0.0925 | $ 1.91 | 2.69 % | $ 1.16 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
29.6 | $ 9.22 | -3.27 % | $ 710 M | USA |
 |
Globus Medical
GMED
|
27.6 | $ 88.19 | 0.31 % | $ 11.9 B | USA |
 |
Inogen
INGN
|
17.4 | $ 6.36 | 2.42 % | $ 169 M | USA |
 |
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.01 | 3.06 % | $ 17.1 M | USA |
 |
IRadimed Corporation
IRMD
|
46 | $ 95.62 | -0.63 % | $ 1.22 B | USA |
 |
Integer Holdings Corporation
ITGR
|
18.2 | $ 85.67 | -1.36 % | $ 2.98 B | USA |
 |
NanoVibronix
NAOV
|
0.955 | - | - | $ 1.08 M | USA |